| 臺大學術典藏 |
2022-09-15T05:42:25Z |
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
|
Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; CHIEN-CHING HUNG; Kao J.-H. |
| 臺大學術典藏 |
2022-09-09T04:21:34Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; Fang Y.-J.; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:27Z |
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
|
Liu C.-H.; Peng C.-Y.; Kao W.-Y.; Yang S.-S.; Shih Y.-L.; Lin C.-L.; Tsai M.-K.; Lee C.-Y.; Chang C.-C.; Wu J.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-09T04:21:16Z |
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
|
Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-02-14T06:28:46Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; YU-JEN FANG; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:45Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.‐Y.; Kao J.-H. |
| 臺大學術典藏 |
2022-02-14T06:28:42Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:13Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; CHUN-JEN LIU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:11Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; CHUN-JEN LIU; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; Fang Y.-J.; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:00Z |
Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
|
Liu C.-H.; Peng C.-Y.; Kao W.-Y.; Yang S.-S.; Shih Y.-L.; Lin C.-L.; Tsai M.-K.; Lee C.-Y.; Chang C.-C.; Wu J.-H.; CHUN-JEN LIU; Su T.-H.; Tseng T.-C.; Chen P.-J.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:58Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:30:53Z |
Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; Fang Y.-J.; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T05:16:46Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:42Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; Fang Y.-J.; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T05:16:17Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-07-03T03:33:31Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu C.-H.;Shih Y.-L.;Yang S.-S.;Lin C.-L.;Fang Y.-J.;Cheng P.-N.;Chen C.-Y.;Peng C.-Y.;Hsieh T.-Y.;Chiu Y.-C.;Su T.-H.;Liu C.-J.;Yang H.-C.;Pei-Jer Chen;Chen D.-S.;Kao J.-H.; Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:21Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
CHEN-HUA LIU; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:20Z |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
CHEN-HUA LIU; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; Fang Y.-J.; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:13Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
CHEN-HUA LIU; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?�Y.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-06T01:25:13Z |
Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan
|
Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; CHIEN-CHING HUNG; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:43:16Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; TUNG-HUNG SU; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-02-18T08:01:11Z |
Corrigendum to: “Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma” [J Hepatol (2020) 121-129] (Journal of Hepatology (2020) 121-129 (S016882782030163X), (10.1016/j.jhep.2020.03.005))
|
Kim N.; Cheng J.; Jung I.; JA-DER LIANG; Shih Y.L.; Huang W.-Y.; Kimura T.; Lee V.H.F.; Zeng Z.C.; Zhenggan R.; Kay C.S.; Heo S.J.; Won J.Y.; Seong J. |
| 臺大學術典藏 |
2021-02-18T08:01:11Z |
Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma
|
Kim N.; Cheng J.; Jung I.; JA-DER LIANG; Shih Y.L.; Huang W.-Y.; Kimura T.; Lee V.H.F.; Zeng Z.C.; Zhenggan R.; Kay C.S.; Heo S.J.; Won J.Y.; Seong J. |
| 臺大學術典藏 |
2021-02-02T02:48:00Z |
Endothelial cell sensitization by death receptor fractions of an anti-dengue nonstructural protein 1 antibody induced plasma leakage, coagulopathy, and mortality in mice
|
Sun D.-S.; Chang Y.-C.; Lien T.-S.; King C.-C.; Shih Y.-L.; Huang H.-S.; Wang T.-Y.; Li C.-R.; Lee C.-C.; PING-NING HSU; Chang H.-H. |
| 臺大學術典藏 |
2020-09-30T03:23:00Z |
Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan
|
Ko W.-C.; Huang C.-K.; Lai C.-H.; Chen Y.-S.; Shih Y.-L.; Chung H.-C.; Liang S.-H.; Lin J.-N.; Liu J.-Y.; Lin H.-H.; Liu Y.-C.; Lee S.S.-J.; Chen Y.-L.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-03-23T04:00:52Z |
Prospective double-blind randomized study on the efficacy and safety of an n-3 fatty acid enriched intravenous fat emulsion in postsurgical gastric and colorectal cancer patients
|
Wang J.-Y.; MING-TSAN LIN; Ma C.-J.;Wu J.-M.;Tsai H.-L.;Huang C.-W.;Lu C.-Y.;Sun L.-C.;Shih Y.-L.;Chen C.-W.;Chuang J.-F.;Wu M.-H.;Wang M.-Y.;Ming-Tsan Lin;Wang J.-Y.; Ma C.-J.; Wu J.-M.; Tsai H.-L.; Huang C.-W.; Lu C.-Y.; Sun L.-C.; Shih Y.-L.; Chen C.-W.; Chuang J.-F.; Wu M.-H.; Wang M.-Y. |
| 臺大學術典藏 |
2020-02-11T01:41:54Z |
Prospective double-blind randomized study on the efficacy and safety of an n-3 fatty acid enriched intravenous fat emulsion in postsurgical gastric and colorectal cancer patients
|
Ma C.-J.;Jin-Ming Wu;Tsai H.-L.;Huang C.-W.;Lu C.-Y.;Sun L.-C.;Shih Y.-L.;Chen C.-W.;Chuang J.-F.;Wu M.-H.;Wang M.-Y.;Lin M.-T.;Wang J.-Y.; Ma C.-J.; JIN-MING WU; Tsai H.-L.; Huang C.-W.; Lu C.-Y.; Sun L.-C.; Shih Y.-L.; Chen C.-W.; Chuang J.-F.; Wu M.-H.; Wang M.-Y.; Lin M.-T.; Wang J.-Y. |
| 臺大學術典藏 |
2020-01-22T07:46:04Z |
Quantitative proteomics analysis reveals the Min system of Escherichia coli modulates reversible protein association with the inner membrane
|
Lee H.-L.;Chiang I.-C.;Liang S.-Y.;Lee D.-Y.;Chang G.-D.;Wang K.-Y.;Lin S.-Y.;Shih Y.-L.; Lee H.-L.; Chiang I.-C.; Liang S.-Y.; Lee D.-Y.; Chang G.-D.; Wang K.-Y.; Lin S.-Y.; Shih Y.-L.; GEEN-DONG CHANG |
| 臺大學術典藏 |
2019-12-10T03:23:21Z |
Optimal scheduling for highway emergency repairs under large-scale supply-demand perturbations
|
Yan, S.; Chu, J.C.; Shih, Y.-L.; CHIH-YUAN CHU |
| 國立成功大學 |
2019 |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu, C.-H.;Shih, Y.-L.;Yang, S.-S.;Lin, C.-L.;Fang, Y.-J.;Cheng, P.-N.;Chen, Chen C.-Y.;Peng, C.-Y.;Hsieh, T.-Y.;Chiu, Y.-C.;Su, T.-H.;Liu, C.-J.;Yang, H.-C.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H. |
| 臺大學術典藏 |
2018-09-10T15:34:08Z |
Involvement of type VI secretion system in secretion of iron chelator pyoverdine in Pseudomonas taiwanensis
|
Chen, W.-J.; Kuo, T.-Y.; Hsieh, F.-C.; Chen, P.-Y.; Wang, C.-S.; Shih, Y.-L.; Lai, Y.-M.; Liu, J.-R.; Yang, Y.-L.; Shih, M.-C.; JE-RUEI LIU |
| 臺大學術典藏 |
2018-09-10T08:09:27Z |
Combination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptors
|
Liu, H.-C.; Chen, C.-S.; Hsu, C.-H.; Pan, M.-H.; Chang, H.-W.; Chang, C.-H.; Chen, F.-C.; Ho, C.-T.; Yang, Y.I.-Y.; Ho, Y.-S.; Shih, Y.-L.; MIN-HSIUNG PAN et al. |
| 臺大學術典藏 |
2018-09-10T07:04:41Z |
Dexamethasone reduced invasiveness of human malignant glioblastoma cells through a MAPK phosphatase-1 (MKP-1) dependent mechanism
|
Lin, Y.-M.;Jan, H.-J.;Lee, C.-C.;Tao, H.-Y.;Shih, Y.-L.;Wei, H.-W.;Lee, H.-M.; Lin, Y.-M.; Jan, H.-J.; Lee, C.-C.; Tao, H.-Y.; Shih, Y.-L.; Wei, H.-W.; Lee, H.-M.; HEN-WEI WEI |
| 臺大學術典藏 |
2018-09-10T07:02:45Z |
Capacitively-loaded loop antenna for multi-band mobile handsets
|
Shih, Y.-L.; Wang, B.-H.; Lu, Y.-J.; Cheng, J.-C.; Chen, S.-Y.; Hsu, P.; SHIH-YUAN CHEN |
| 國立成功大學 |
2017 |
Dual-band FPC dipole with pattern reconfiguration for wifi application
|
Chiu, T.-W.;Shih, Y.-L.;Lee, W.-H.;Zhang, J.-H. |
| 國立成功大學 |
2017 |
Ankylosing spondylitis and the risk of cancer
|
Chang, Chang C.-C.;Chang, Chang C.-W.;Nguyen, P.-A.A.;Chang, T.-H.;Shih, Y.-L.;Chang, W.-Y.;Horng, J.-T.;Lee, O.K.-S.;Ho, J.H.-C. |
| 國立成功大學 |
2014 |
RESEARCH ON ENERGY-SAVING DESIGN TRANSFORMATION ON THE EXTERNAL SHELL OF EXISTING BUILDINGS-THE EXAMPLE OF KAOHSIUNG CITY TOWNHOUSES
|
Liu, K. S.; Shih, Y. L.; Tzeng, C. T.; Chen, C. C. |
| 輔英科技大學 |
2011-05-01 |
Rubella seroepidemiology and estimations of the catch-up immunization rate and persistence of antibody titers in pregnant women in Taiwan
|
Lin , C.C.;Yang, C.Y ;Shih, Y.L. ;Hsu, H.W. ;Yang, T.H. ;Cheng,Y.W. ;Chang, C.F. ; Hsieh , L.C.; Chen , B.H.; Lee , C.H.; Huang , Y.L. |
| 中原大學 |
2009-05 |
Equilibrium Isotherm of Gases from Heat Decomposition of Polymers on Activated Carbon
|
Lai, M.-H.; Shih, Y.-L.; Chang, J.-M., Chen; Y.-H., Chung, T.-W. |
